Drugs in Context Gastroenterology welcomes a broad range of article types including original research, study protocols and review articles.
In line with the principle of providing context for healthcare professionals (HCPs) to properly inform and improve disease management in real world medicine, we especially encourage the submission of articles that provide context for trials of drug interventions in order to motivate improvements in disease management by HCPs practising medicine in the front line.
Review
This review discusses the clinical features, diagnosis and available treatments for major liver diseases, acting as an introduction to a clinical case collection based on the management and treatment of major liver diseases with silymarin.
Review
This review summarizes the current knowledge about metabolic-associated fatty-liver disease (MAFLD) and reports the opinion of a group of experts on the increasing prevalence and burden of the disease in the southeast Asia region, the current journey of patients with MAFLD in developing countries, the role of oxidative stress and antioxidant treatment, and the importance of a multidisciplinary approach for early diagnosis and disease management.
Original Research
This study aims to evaluate the efficacy and safety of itopride in addressing upper gastrointestinal symptoms associated with gastroparesis specifically in patients with diabetes. By assessing the impact of itopride SR on symptom relief, this research intends to provide valuable insights into the potential benefits of itopride as a treatment option for gastroparesis.
Original Research
This article aims to evaluate and compare the effects of xyloglucan–gelatin and xyloglucan–gelose associations on E. coli LPS-induced enteritis using a rat model of intestinal hyperpermeability and mucosal inflammation.
Original Research
This study was aimed towards understanding the current status of dietary therapy for patients with pancreatic exocrine insufficiency in Japan and its alignment with Japanese recommendations for high-fat intake and concomitant high-potency pancreatic enzyme replacement therapy by surveying treating physicians and registered dietitians.
